"The pandemic threat gave us an opportunity to accelerate our growth, paving the way for a promising outlook throughout the current fiscal year and over the longer term. Our expected sales growth will improve our financial performance," added Mr. Leroux. "During the year, we concluded new agreements and partnerships that are already bearing fruit, as attested to by our significant order book for Noveko(TM) antimicrobial face masks and respirators and AZURO(TM) hand sanitizers, also demonstrating the greater interest in our know-how and expertise. In addition, we managed to have our suppliers increase their production capacity in order to meet the growing demand, thereby enabling us to better serve our clients."

"Integrating the acquired entities into our group, and especially pooling our technologies, allowed us to achieve significant breakthroughs in the air filtration segment, notably in the farming sector, although the market deployment of our Noveko antimicrobial air filters was not as rapid as expected, due to the difficult conditions currently prevailing in the swine industry. We are however confident of being well positioned to benefit from an eventual recovery. We also believe that the current fiscal year will be promising in regard to new applications for our air filters in the aeronautics, rail transport and building segments."

"All in all, we have the assets, organizational capabilities and human resources to further develop our primary growth vectors, namely our antimicrobial face masks and respirators, air filtration products, sanitizers and medical equipment," concluded Mr. Leroux.

Source: NOVEKO INTERNATIONAL INC.